Company Profile
Keapstone Therapeutics Limited
10594127•Private Limited With Share Capital
Get Full Access
01/02/2017
9 years
4
—
72110
moderate risk
Company Overview
Registration, classification & business activity
Keapstone Therapeutics Limited (10594127) is a private limited with share capital incorporated on 01/02/2017 (9 years old) and registered in sheffield, S14DP. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Keapstone therapeutics is a single asset biotech developing drugs that target the nrf2 signalling pathway (keap1 inhibitors) for two devastating conditions – parkinson’s and motor neuron disease (mnd) – which together affect more than 130,000 people in the uk. keapstone was co-founded in february 20...
Financial Overview
£22.7K
£198.6K
£-175.9K
£0
Key Metrics
4
Directors
4
Shareholders
Board of Directors
Risk Assessment
moderate risk
International Score
Future Factor
fair
Performance Rating